FDA Warns Supplement Companies over Health Claims and GMP Violations

Drug Industry Daily
A A
The FDA continued its crackdown on supplement companies over drug claims and cGMP violations, warning companies in New York and Alabama.

To View This Article:

Login

Subscribe To Drug Industry Daily